Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Among 451 incident cases of papillary thyroid cancer and ...
Time interval between final protocol approval (FPA) and inclusion of the first patient into randomized clinical trials (RCTs) performed by the Central European Cooperative Oncology Group (CECOG): A 10 ...
Investigators conducted a nested case-control study of women aged ≥ 40 years from the general population of Sweden for the years 2009-2019. Analyses assessed menopausal hormone therapy use among 943 ...
A large case-control study found that adverse drug effects in patients with autoimmune rheumatologic diseases were more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results